Kythera Biophrarma (KYTH) Tops Q1 EPS by 236c

Kythera Biophrarma (NASDAQ: KYTH) reported Q1 EPS of $1.24, $2.36 better than the analyst estimate of ($1.12).

For earnings history and earnings-related data on Kythera Biophrarma (KYTH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c